Codan Limited

CODAF · OTC

Low target$0.00
Average target$0.00
High target$0.00

Analyst ratings

hold · 0 ratings

DateFirmActionRatingPrice target

Growth trajectory and earnings forecast reliability

Bull case

Codan is forecast to grow earnings and revenue by 14.8% and 11.5% per annum respectively, with return on equity projected at 27.1% in three years. Strong technical momentum, including a Golden Star Signal and consistent buy signals from both short- and long-term moving averages, reinforces confidence in sustained growth.

Bear case

Despite strong forecasts, analyst consensus reveals a wide price target dispersion — from a low of $27.00 to a high of $48.74 — signalling deep uncertainty about the reliability of earnings projections. Multiple downgrades from UBS and Macquarie in mid-2025 suggest meaningful skepticism about near-term growth delivery.

Competitive positioning in defense and communications markets

Bull case

Codan's robust exposure to defense and critical communications segments provides meaningful insulation from the broader consumer-tech slowdown and memory-driven supply chain disruptions. These resilient end-markets are driving sector rotation flows back into the stock, with a forecast weighted return of +3.9% across multiple horizons.

Bear case

The broader technology sector faces looming IT guidance cuts amid macroeconomic uncertainty, and chip-related sell-offs continue to ripple across Asian markets. Analysts holding 'Hold' ratings, including UBS and Macquarie, appear unconvinced that Codan's niche positioning is sufficient to fully offset these macro headwinds.

Stock valuation and near-term price target justification

Bull case

Codan's stock has delivered a five-year performance of +137.94%, and technical analysis indicates it is trading within a strong rising trend. With a projected 26.36% price appreciation over the next three months and support from accumulated volume levels, the current valuation is seen as offering an attractive risk-reward entry point.

Bear case

The average 12-month analyst price target of $43.15 implies a modest +0.77% upside from current levels, with UBS maintaining a 'Hold' at $42.50. The presence of one 'Sell' rating and three 'Hold' ratings among nine analysts suggests a significant portion of the analyst community views the stock as fully valued or overextended.